Finance

Senarai
Sebab 3692 meningkat 2.62%?
Terokai Dengan Lebih Terperinci
3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$31.38
+2.62%
(+0.80) 1H
15 Okt, 4:08:33 PTG GMT+8  ·   HKD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 3692...
Buka
HK$30.58
Tinggi
HK$31.70
Rendah
HK$30.58
Permodalan Pasaran
190.29B
Purata volum
8.56J
Volum
10.47J
Dividen
1.55%
Dividen suku tahunan
HK$0.12
Tarikh tanpa dividen
22 Sep 2026
Nisbah H/P
24.23
tgi 52 mgu
HK$44.22
rdh 52 mgu
HK$28.06
EPS
HK$1.30
Bilangan pekerja
10K
Buka
HK$30.58
Tinggi
HK$31.70
Rendah
HK$30.58
Permodalan Pasaran
190.29B
Purata volum
8.56J
Volum
10.47J
Dividen
1.55%
Dividen suku tahunan
HK$0.12
Tarikh tanpa dividen
22 Sep 2026
Nisbah H/P
24.23
tgi 52 mgu
HK$44.22
rdh 52 mgu
HK$28.06
EPS
HK$1.30
Bilangan pekerja
10K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China. Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019. In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Perihal Hansoh Pharmaceutical Group Company Ltd
CEO-
Pekerja9.64K
Diasaskan1995
Ibu pejabat-
Sektor-
Laman webhspharm.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
3.80B
3.80B
4.15B
4.15B
Kos barangan yang dijual
420.88J
420.88J
336.81J
336.81J
Kos hasil
420.88J
420.88J
336.81J
336.81J
Perbelanjaan penyelidikan dan pembangunan
958.57J
958.57J
869.69J
869.69J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
1.29B
1.29B
1.09B
1.09B
Belanja kendalian
2.25B
2.25B
1.97B
1.97B
Jumlah belanja kendalian
2.67B
2.67B
2.31B
2.31B
Pendapatan kendalian
1.12B
1.12B
1.84B
1.84B
Pendapatan bukan kendalian lain
31.11J
31.11J
28.34J
28.34J
EBT termasuk item luar biasa
1.43B
1.43B
2.50B
2.50B
EBT tidak termasuk item luar biasa
1.42B
1.42B
2.46B
2.46B
Belanja cukai pendapatan
220.95J
220.95J
375.70J
375.70J
Kadar cukai berkesan
15.44%
15.44%
15.00%
15.00%
Belanja kendalian lain
6.65J
6.65J
9.48J
9.48J
Pendapatan bersih
1.21B
1.21B
2.13B
2.13B
Margin untung bersih
31.87%
31.87%
51.28%
51.28%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
284.14J
284.14J
630.79J
630.79J
Belanja faedah
-764.50K
-764.50K
-24.31J
-24.31J
Belanja faedah bersih
283.37J
283.37J
606.48J
606.48J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
1.21B
1.21B
1.93B
1.93B
Keuntungan atau kerugian daripada jualan aset
-1.70J
-1.70J
-5.55J
-5.55J
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google